SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-17-002322
Filing Date
2017-01-13
Accepted
2017-01-13 16:20:51
Documents
4
Period of Report
2016-10-31
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a17-1910_18ka.htm 8-K/A 35087
2 EX-23.1 a17-1910_1ex23d1.htm EX-23.1 2757
3 EX-99.1 a17-1910_1ex99d1.htm EX-99.1 64428
4 EX-99.2 a17-1910_1ex99d2.htm EX-99.2 752882
  Complete submission text file 0001104659-17-002322.txt   856225
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37691 | Film No.: 17528066
SIC: 2834 Pharmaceutical Preparations